Similar articles

• Experience with ketanserin and ritanserin in hypertensive patients.

  Hedner T, Persson B. Hedner T, et al. J Cardiovasc Pharmacol. 1988;11 Suppl 1:S44-8. J Cardiovasc Pharmacol. 1988. PMID: 2459514 Clinical Trial.
• [What does the introduction of ketanserin for the treatment of arterial hypertension represent?].

  Rorive G, Carlier PG, Krzesinski JM. Rorive G, et al. Rev Med Liege. 1988 Mar;43 Suppl 1:50-4. Rev Med Liege. 1988. PMID: 3375650 French. No abstract available.
• Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.

  Podoleanu D, Cotoi S. Podoleanu D, et al. Rom J Intern Med. 1996 Jan-Jun;34(1-2):49-54. Rom J Intern Med. 1996. PMID: 8908630
• The rationale for ketanserin therapy in hypertension.

  Hansson L, Hedner T. Hansson L, et al. J Cardiovasc Pharmacol. 1987;10 Suppl 3:S39-44. J Cardiovasc Pharmacol. 1987. PMID: 2446068 Review.
• [Mechanism of action and use of antagonists of serotonin receptors S2, especially ketanserin, in the treatment of various diseases of the cardiovascular system].

  Wiecek A, Grzeszczak W. Wiecek A, et al. Pol Tyg Lek. 1987 Mar 9;42(10):304-8. Pol Tyg Lek. 1987. PMID: 3299308 Review. Polish. No abstract available.